Calcagni, Maria Lucia
 Distribuzione geografica
Continente #
NA - Nord America 5.979
EU - Europa 5.042
AS - Asia 4.446
SA - Sud America 810
AF - Africa 99
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.394
Nazione #
US - Stati Uniti d'America 5.847
SG - Singapore 1.982
DE - Germania 1.665
CN - Cina 1.154
SE - Svezia 733
IT - Italia 659
BR - Brasile 641
VN - Vietnam 452
FR - Francia 365
PL - Polonia 353
UA - Ucraina 301
GB - Regno Unito 278
IE - Irlanda 191
IN - India 189
FI - Finlandia 130
ID - Indonesia 126
RU - Federazione Russa 126
JP - Giappone 102
HK - Hong Kong 84
AR - Argentina 69
CA - Canada 62
TR - Turchia 59
BD - Bangladesh 56
NL - Olanda 46
MX - Messico 42
IQ - Iraq 34
AT - Austria 30
ZA - Sudafrica 30
ES - Italia 28
BE - Belgio 26
IR - Iran 24
KR - Corea 24
SA - Arabia Saudita 23
EC - Ecuador 22
LT - Lituania 21
CH - Svizzera 18
CO - Colombia 18
CZ - Repubblica Ceca 15
CI - Costa d'Avorio 14
MA - Marocco 14
PK - Pakistan 14
RO - Romania 13
UZ - Uzbekistan 13
CL - Cile 12
VE - Venezuela 12
AU - Australia 11
IL - Israele 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
MY - Malesia 9
PH - Filippine 9
PY - Paraguay 9
UY - Uruguay 9
AZ - Azerbaigian 8
EG - Egitto 8
JM - Giamaica 8
OM - Oman 8
PE - Perù 8
BO - Bolivia 7
DK - Danimarca 7
KE - Kenya 7
TN - Tunisia 7
TW - Taiwan 7
NP - Nepal 6
DZ - Algeria 5
LB - Libano 5
AL - Albania 4
DO - Repubblica Dominicana 4
LV - Lettonia 4
MD - Moldavia 4
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BB - Barbados 2
BS - Bahamas 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
Totale 16.375
Città #
Singapore 1.048
Chandler 779
Ashburn 689
San Jose 463
Warsaw 333
Jacksonville 194
Dublin 187
Beijing 180
New York 167
San Mateo 162
Ho Chi Minh City 147
Nanjing 147
Wilmington 146
Fairfield 145
Ann Arbor 127
Munich 122
Milan 119
Hanoi 117
Woodbridge 117
Jakarta 114
Los Angeles 112
Rome 110
Lauterbourg 106
Dearborn 96
Seattle 96
Houston 95
Nürnberg 95
Chicago 89
Hefei 86
Tokyo 85
Boston 83
Frankfurt am Main 78
Hong Kong 76
São Paulo 73
Moscow 72
The Dalles 70
Cattolica 64
Nanchang 61
Princeton 59
Dallas 55
Redmond 55
Bremen 53
Boardman 46
Helsinki 45
Lawrence 44
Zhengzhou 43
Cambridge 41
Marseille 41
Shanghai 41
Lancaster 40
Redwood City 37
Buffalo 36
London 35
Izmir 31
Kunming 31
Norwalk 31
Santa Clara 31
Hyderabad 30
Da Nang 28
Tianjin 28
Falls Church 27
Pune 27
Toronto 27
Council Bluffs 25
Hebei 25
Kent 25
Brooklyn 23
Hangzhou 23
Mountain View 23
Nuremberg 23
Orem 23
Atlanta 22
Brussels 22
Changsha 21
Leawood 21
Jiaxing 20
Paris 20
Seoul 20
Shenyang 19
Vienna 19
University Park 18
Belo Horizonte 16
St Louis 16
Stockholm 16
Augusta 15
Guangzhou 15
Rio de Janeiro 15
Abidjan 14
Chennai 14
Düsseldorf 14
Phoenix 14
Amsterdam 13
Columbus 13
Detroit 13
San Francisco 13
Baghdad 12
Lappeenranta 12
Padova 12
Salt Lake City 12
Turku 12
Totale 8.665
Nome #
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 360
18F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports 286
Early evaluation of cerebral metabolic rate of glucose (CMRglu) with 18F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement: preliminary experience 280
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 272
Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report 265
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 229
123I-MIBG Radioaerosol lung clearance in COPD patients with fixed and partially reversible obstruction to evacuate the functional status of pulmonary adrenergic innervation 220
Are the simplified methods to estimate Ki in 18F-FDG PET studies feasible in clinical routine? Comparison between three simplified methods. 218
123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study 211
A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features. 206
Comparison of three-parameter kinetic model analysis to standard Patlak’s analysis in 18 F-FDG PET imaging of lung cancer patients 204
Ictal brain spet during seizures pharmacologically provoked with pentylenetetrazol: a new diagnostic procedure in drug resistant epileptic patients 200
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 199
Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy. 198
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 196
11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis 192
Automated detection and classification of tumor histotypes on dynamic PET imaging data through machine-learning driven voxel classification 192
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 187
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 183
Spinal Cord stimulation and cerebral blood flow in stroke: personal experience 182
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 180
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose 179
Dopamine transporter binding in depressed patients with anhedonia 174
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 169
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 168
Effect of spinal cord stimulation on cardiac adrenergic nerve function in patients with cardiac syndrome x 168
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 165
The kinetics of 18F-FDG in lung cancer: compartmental models and voxel analysis 164
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 164
Cardiac adrenergic nerve function in patients with cardiac syndrome X 163
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 163
Middle cerebral artery dolichoectasia in a young woman with a previous stroke 162
Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging 162
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Application of Artificial Neural Network to Preoperative 18F-FDG PET/CT for Predicting Pathological Nodal Involvement in Non-small-cell Lung Cancer Patients 160
Neural correlates of psychodynamic psychotherapy in borderline disorders--a pilot investigation. 159
imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls 159
Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT 158
Decompressive craniectomy and hydrocephalus: proposal of a therapeutic flow-chart 158
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy 157
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 156
A Rare Case of Primary Thymic Hodgkin Lymphoma in an Elderly Patient Detected by 18F-FDG PET/CT. 156
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 155
Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment 153
Regional metabolic rate of glucose (CMRglu) evaluation and clinical assessment in idiopathic normal-pressure hydrocephalus (iNPH) patients before and after ventricular shunt placement. A prospective analysis 153
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 152
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 152
The role of nuclear medicine in the management of thymomas. 150
Cerebral metabolic rate for glucose of NPH patients increases in shunt-reponders 149
The prognostic value of 18f-fdg pet imaging at staging in patients with malignant pleural mesothelioma: A literature review 149
The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review 148
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 146
Cognitive Impairment in chronic obstructive pulmonary disease: a neuropsychological and spect study 146
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma 145
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 144
Neuroadrenergic Denervation of the lung in type I diabetes mellitus complicated by autonomic neuropathy 143
SPECT myocardial perfusion imaging. Long-term prognostic value in diabetic patients with and without coronary artery disease 140
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 139
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 137
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls 136
Dynamic11 c-methionine pet-ct: Prognostic factors for disease progression and survival in patients with suspected glioma recurrence 136
Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review 135
Metabolic Rate of glucose (MRglu) but not standardized uptake value (SUV) can distinguish high risk from low risk uveal melanoma: experience in 20 patients 133
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 130
A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT 129
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy 129
Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome 127
Diagnostic role of 11C-methionine PET/CT in patients with multiple myeloma and other plasma cell malignancy: a literature review 127
Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest 125
Usefulness of brain positron emission tomography with different tracers in the evaluation of patients with idiopathic normal pressure hydrocephalous 124
18 F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules 123
Topical delivery of nerve growth factor for treatment of ocular and brain disorders 123
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 122
18F-FDG and 68Ga-DOTATOC PET/CT Findings in a Case of Abdominal Leiomyosarcoma 122
The quantification with FDG as seen by a physician. 121
Short 2-[18F]Fluoro-2-Deoxy-D-Glucose PET Dynamic Acquisition Protocol to Evaluate the Influx Rate Constant by Regional Patlak Graphical Analysis in Patients With Non-Small-Cell Lung Cancer 120
Malignant pleural mesothelioma: utility of 18 F-FDG PET. 118
Evaluation of age and sex-related metabolic changes in healthy subjects: An italian brain 18f-fdg pet study 116
PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review 115
Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. 114
Serial neuroimaging findings in a novel case of sporadic progressive ataxia and palatal tremor (PAPT) 113
Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report 112
Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters 111
Framing doctor-managers’ resilience during Covid-19 pandemic: A descriptive analysis from the Italian NHS 110
Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands 108
Optic nerve glioblastoma detected by11C-Methionine brain PET/CT 108
The scintigraphic prediction of residual lung function after lobectomy in patients with bronchial carcinoma 106
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 106
Comparison between 18F-FDG and 18F-NaF PET imaging for assessing bone metastases in breast cancer patients: a literature review 104
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 103
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 102
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 100
Usefulness of 18F-FDG PET/CT in a Rare Case of Malignant Pseudothyroiditis 98
Is 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography useful to discriminate metachronous lung cancer from metastasis in patients with oncological history? 98
Response evaluation with F-18-FDG PET/CT in metastatic breast cancer patients treated with Palbociclib: first experience in clinical practice 98
Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps 97
Radiolabelled Trastuzumab PET/CT imaging: a promising non-invasive tool for the in vivo assessment of HER2 status in breast cancer patients 96
99Tc ECD brain perfusion in obstructive sleep apnea syndrome: a new SPET finding 96
How Often Do We Fail to Classify the Treatment Response with [ 18 F]FDG PET/CT Acquired on Different Scanners? Data from Clinical Oncological Practice Using an Automatic Tool for SUV Harmonization 93
Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies. 93
Totale 15.263
Categoria #
all - tutte 61.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 0 0 0 0 0 0 0 0 0 85 141 31
2021/20221.132 109 92 24 78 77 48 36 151 50 61 191 215
2022/20232.271 281 306 158 343 128 285 98 189 276 56 95 56
2023/20241.178 50 264 40 45 59 185 62 84 20 47 145 177
2024/20252.147 59 55 157 90 230 85 87 102 338 248 397 299
2025/20265.317 831 176 339 566 1.014 315 1.064 278 396 338 0 0
Totale 16.615